| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Aridis Pharmaceuticals, Inc. | CFO | Stock Options | 84,575 | 04 May 2023 | Direct | ||
| Aridis Pharmaceuticals, Inc. | CFO | Common Stock | 4,000 | 05 Jun 2023 | Direct | ||
| Aridis Pharmaceuticals, Inc. | CFO | Restricted Stock Units | 4,000 | 05 Jun 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000149315223021470-kurland-fred-2023-05-04 | Aridis Pharmaceuticals, Inc. | 04 May 2023 | 3 | $0 | 4 | CFO | 15 Jun 2023, 17:09 |
| /report/000149315222034678-kurland-fred-2022-12-05 | Aridis Pharmaceuticals, Inc. | 05 Dec 2022 | 1 | $0 | 4 | Chief Financial Officer | 07 Dec 2022, 07:59 |
| /report/000110465921123271-kurland-fred-2021-10-04 | Aridis Pharmaceuticals, Inc. | 04 Oct 2021 | 1 | $0 | 4 | CFO | 05 Oct 2021, 18:43 |